Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of weekly palifermin to reduce severe oral mucositis during chemoradiotherapy for advanced head and neck cancer
2005-000213-35Phase 3Completed
- Sponsor
- Sobi
- Start
- Jul 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in stomatitis comparing Palifermin + chemoradiotherapy with Placebo + chemoradiotherapy (2 arms). Primary endpoint: Incidence of severe oral mucositis. Started Jul 2005; status: completed.
02
Drugs
palifermin
03
Conditions
stomatitis
Beyond the preview
Go deeper on 2005-000213-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000213-35.